NO175372C - Analogifremgangsmåte for framstilling av et terapeutisk aktivt polypeptid - Google Patents

Analogifremgangsmåte for framstilling av et terapeutisk aktivt polypeptid

Info

Publication number: NO175372C
Authority: NO; Norway
Prior art keywords: preparing; therapeutically active; active polypeptide; analogous method; same
Prior art date: 1987-08-21

Application number

NO891572A

Other languages

English (en)

Norwegian (no)

Other versions

NO891572L (no

NO891572D0 (no

NO175372B (no

Inventor

Takanori Nakamura

Sadaaki Iwanaga

Motonori Ohno

Kyosuke Miyazaki

Original Assignee

Seikagaku Kogyo Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1987-08-21

Filing date

1989-04-18

Publication date

1994-10-05

1989-04-18 Application filed by Seikagaku Kogyo Co Ltd filed Critical Seikagaku Kogyo Co Ltd

1989-04-18 Publication of NO891572D0 publication Critical patent/NO891572D0/no

1989-05-09 Publication of NO891572L publication Critical patent/NO891572L/no

1994-01-10 Priority to NO940078A priority Critical patent/NO178663C/no

1994-06-27 Publication of NO175372B publication Critical patent/NO175372B/no

1994-10-05 Publication of NO175372C publication Critical patent/NO175372C/no

Links

229920001184 polypeptide Polymers 0.000 title abstract 3
102000004196 processed proteins & peptides Human genes 0.000 title abstract 3
108090000765 processed proteins & peptides Proteins 0.000 title abstract 3
DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 abstract 3
AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 abstract 2
COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 abstract 2
OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 abstract 2
KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 abstract 2
KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Chemical compound CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 abstract 2
239000002158 endotoxin Substances 0.000 abstract 2
OIXLLKLZKCBCPS-RZVRUWJTSA-N (2s)-2-azanyl-5-[bis(azanyl)methylideneamino]pentanoic acid Chemical compound OC(=O)[C@@H](N)CCCNC(N)=N.OC(=O)[C@@H](N)CCCNC(N)=N OIXLLKLZKCBCPS-RZVRUWJTSA-N 0.000 abstract 1
208000035143 Bacterial infection Diseases 0.000 abstract 1
LEVWYRKDKASIDU-QWWZWVQMSA-N D-cystine Chemical compound OC(=O)[C@H](N)CSSC[C@@H](N)C(O)=O LEVWYRKDKASIDU-QWWZWVQMSA-N 0.000 abstract 1
239000004471 Glycine Substances 0.000 abstract 1
QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 abstract 1
KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 abstract 1
239000004472 Lysine Substances 0.000 abstract 1
QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 abstract 1
125000003277 amino group Chemical group 0.000 abstract 1
208000022362 bacterial infectious disease Diseases 0.000 abstract 1
229960003067 cystine Drugs 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 abstract 1
229960000310 isoleucine Drugs 0.000 abstract 1
229920006008 lipopolysaccharide Polymers 0.000 abstract 1
COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 abstract 1
229940124597 therapeutic agent Drugs 0.000 abstract 1
OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 abstract 1
239000004474 valine Substances 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Genetics & Genomics (AREA)
Biochemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Immunology (AREA)
Gastroenterology & Hepatology (AREA)
Dermatology (AREA)
Rheumatology (AREA)
Communicable Diseases (AREA)
Pain & Pain Management (AREA)
Oncology (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Medicinal Preparation (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

NO891572A 1987-08-21 1989-04-18 Analogifremgangsmåte for framstilling av et terapeutisk aktivt polypeptid NO175372C (no)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
NO940078A NO178663C (no)	1987-08-21	1994-01-10	Framgangsmåte for framstilling av et terapeutisk aktivt polypeptid

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP20625887		1987-08-21
PCT/JP1988/000823 WO1989001492A1 (fr)	1987-08-21	1988-08-19	Nouveau polypeptide et procede de prepration

Publications (4)

Publication Number	Publication Date
NO891572D0 NO891572D0 (no)	1989-04-18
NO891572L NO891572L (no)	1989-05-09
NO175372B NO175372B (no)	1994-06-27
NO175372C true NO175372C (no)	1994-10-05

Family

ID=16520353

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
NO891572A NO175372C (no)	1987-08-21	1989-04-18	Analogifremgangsmåte for framstilling av et terapeutisk aktivt polypeptid
NO940078A NO178663C (no)	1987-08-21	1994-01-10	Framgangsmåte for framstilling av et terapeutisk aktivt polypeptid

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
NO940078A NO178663C (no)	1987-08-21	1994-01-10	Framgangsmåte for framstilling av et terapeutisk aktivt polypeptid

Country Status (13)

Country	Link
US (2)	US5068314A (fr)
EP (1)	EP0343248B1 (fr)
JP (1)	JP2710653B2 (fr)
KR (1)	KR970001811B1 (fr)
CN (1)	CN1031193C (fr)
AT (1)	ATE88480T1 (fr)
AU (1)	AU642089B2 (fr)
CA (2)	CA1337781C (fr)
DE (1)	DE3880481T2 (fr)
DK (1)	DK193589A (fr)
FI (1)	FI92708C (fr)
NO (2)	NO175372C (fr)
WO (1)	WO1989001492A1 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA1337781C (fr) *	1987-08-21	1995-12-19	Takanori Nakamura	Polypeptide provenant de la limule, manifestant de l'affinite pour les lipopolysaccharides; methode de preparation
US5594113A (en) *	1988-06-23	1997-01-14	Associates Of Cape Cod, Inc.	Endotoxin binding and neutralizing protein and uses thereof
FI922044A0 (fi) *	1990-09-11	1992-05-06	Seikagaku Kogyo Co Ltd	Ny polypeptid och daerav framstaelld hiv-medicin.
EP0549102B1 (fr) *	1991-12-25	1996-07-03	Maruha Corporation	Réactifs et procédés pour déterminer des Beta-Glucanes
JP3361830B2 (ja) *	1992-03-30	2003-01-07	生化学工業株式会社	抗菌性組成物及びそれを有効成分とする薬剤
EP0572688B1 (fr) *	1992-05-30	1997-05-07	Predrag Dr.Sc. Sikiric	Peptides de BPC, leur préparation et utilisation
JP3402476B2 (ja) *	1992-08-24	2003-05-06	生化学工業株式会社	リポ多糖結合性タンパク質及びその製造法
CA2112776C (fr) *	1993-01-21	2002-11-12	Masakazu Tsuchiya	Methode pour inhiber l'activite d'une endotoxine
WO1995005393A2 (fr)	1993-08-18	1995-02-23	Morphosys Gesellschaft Für Proteinoptimierung Mbh	Peptides liant et neturalisant les lipopolysaccharides
JPH08504837A (ja) *	1993-10-14	1996-05-28	生化学工業株式会社	新規ポリペプチドおよびこれから調製される抗ｈｉｖ剤
KR100257310B1 (ko) *	1996-12-21	2000-05-15	정몽규	트렁크 리드 개폐장치
US6011066A (en) *	1998-02-02	2000-01-04	Veterans General Hospital-Taipei	Method for treating septic shock
CN100389140C (zh) *	2006-05-12	2008-05-21	北京理工大学	由聚肽-b-聚四氢呋喃-b-聚肽三嵌段共聚物制备纳米及微米级自组装体的方法
WO2011008863A2 (fr) *	2009-07-14	2011-01-20	Lucia Irene Gonzalez	Peptides stéréoisomères et leurs conjugués polymères pour infection par le vih
CN108623659B (zh) *	2018-03-17	2021-09-14	中国海洋大学	一种氨基酸全部选用d型氨基酸的抗菌肽合成方法
WO2021183061A1 (fr) *	2020-03-13	2021-09-16	Vet Products Research And Innovation Center Company Limited	Peptides antimicrobiens pour l'inhibition de micro-organismes pathogènes dans les voies digestives et respiratoires chez l'animal

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4663435A (en) *	1982-12-06	1987-05-05	Merck & Co., Inc.	Bridged cyclic hexapeptide somatostatin analogs
CA1337781C (fr) *	1987-08-21	1995-12-19	Takanori Nakamura	Polypeptide provenant de la limule, manifestant de l'affinite pour les lipopolysaccharides; methode de preparation

1988
- 1988-08-18 CA CA000575083A patent/CA1337781C/fr not_active Expired - Fee Related
- 1988-08-19 DE DE8888907358T patent/DE3880481T2/de not_active Expired - Fee Related
- 1988-08-19 EP EP88907358A patent/EP0343248B1/fr not_active Expired - Lifetime
- 1988-08-19 JP JP63505336A patent/JP2710653B2/ja not_active Expired - Lifetime
- 1988-08-19 AT AT88907358T patent/ATE88480T1/de not_active IP Right Cessation
- 1988-08-19 KR KR1019890700677A patent/KR970001811B1/ko not_active Expired - Fee Related
- 1988-08-19 US US07/348,487 patent/US5068314A/en not_active Expired - Fee Related
- 1988-08-19 WO PCT/JP1988/000823 patent/WO1989001492A1/fr not_active Ceased
- 1988-08-20 CN CN88106207A patent/CN1031193C/zh not_active Expired - Fee Related
1989
- 1989-04-18 NO NO891572A patent/NO175372C/no not_active IP Right Cessation
- 1989-04-19 FI FI891873A patent/FI92708C/fi not_active IP Right Cessation
- 1989-04-20 DK DK193589A patent/DK193589A/da not_active Application Discontinuation
1991
- 1991-12-12 CA CA000616257A patent/CA1337782C/fr not_active Expired - Fee Related
1992
- 1992-05-20 AU AU17028/92A patent/AU642089B2/en not_active Ceased
- 1992-08-07 US US07/926,965 patent/US5416194A/en not_active Expired - Fee Related
1994
- 1994-01-10 NO NO940078A patent/NO178663C/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
ATE88480T1 (de)	1993-05-15
JP2710653B2 (ja)	1998-02-10
NO891572L (no)	1989-05-09
DE3880481D1 (de)	1993-05-27
US5068314A (en)	1991-11-26
CN1031379A (zh)	1989-03-01
AU642089B2 (en)	1993-10-07
CA1337781C (fr)	1995-12-19
NO178663C (no)	1996-05-08
NO891572D0 (no)	1989-04-18
FI92708C (fi)	1994-12-27
DK193589A (da)	1989-06-16
EP0343248A1 (fr)	1989-11-29
NO178663B (no)	1996-01-29
KR890701624A (ko)	1989-12-21
WO1989001492A1 (fr)	1989-02-23
AU1702892A (en)	1992-07-16
NO175372B (no)	1994-06-27
AU620345B2 (en)	1992-02-20
FI891873A0 (fi)	1989-04-19
AU2311388A (en)	1989-03-09
US5416194A (en)	1995-05-16
FI891873A7 (fi)	1989-04-19
FI92708B (fi)	1994-09-15
NO940078D0 (no)	1994-01-10
JPH02500194A (ja)	1990-01-25
CA1337782C (fr)	1995-12-19
EP0343248B1 (fr)	1993-04-21
NO940078L (no)	1989-05-09
DK193589D0 (da)	1989-04-20
DE3880481T2 (de)	1993-09-09
KR970001811B1 (ko)	1997-02-15
CN1031193C (zh)	1996-03-06

Legal Events

Date	Code	Title	Description
2003-04-07	MM1K	Lapsed by not paying the annual fees	Free format text: LAPSED IN FEBRUARY 2003

Publication	Publication Date	Title
NO175372C (no)	1994-10-05	Analogifremgangsmåte for framstilling av et terapeutisk aktivt polypeptid
EP0341915A3 (fr)	1990-12-12	Peptides antiagrégatifs
DE59007517D1 (de)	1994-11-24	Neue proteine mit tnf-hemmender wirkung und ihre herstellung.
AU1377092A (en)	1992-09-15	Peptides for treatment
Ozols	1970	Amino acid sequence of rabbit liver microsomal cytochrome b5
AU1599892A (en)	1992-11-05	Novel polypeptides with affinity to lipopolysaccharides and their uses
EP0976402A3 (fr)	2001-12-12	Vaccins pour la prévention d' infections à bactéries gram-négatifs et de maladies dues aux endotoxines
Kuromizu et al.	1986	Reexamination of the primary structure of an antitumor protein, neocarzinostatin
Craig et al.	1949	Purity studies on polypeptide antibiotics: bacitracin
AU671989B2 (en)	1996-09-19	Treatment of tropical spastic paresis with peptide T
WO2001027136A3 (fr)	2001-12-13	Peptides ayant une activite de stimulation de la reponse immunitaire et de regeneration tissulaire
AU585167B2 (en)	1989-06-08	Novel substrate peptides
RU94024392A (ru)	1996-05-20	Минерально-аминокислотный концентрат
RU94046096A (ru)	1996-07-20	Линейные или циклические пептиды, их применение, способы лечения и конъюгаты пептидов
KOTAKI et al.	1962	Studies on Insulin: IV. On the Amino Acid Composition of the Glvcyl Chain of Bonito Insulin-I
DE69813232D1 (de)	2003-05-15	Wespe pompilid neuropeptide
CA2216704A1 (fr)	1996-10-10	Nouveaux peptides et medicaments pour les maladies osseuses contenant ces peptides comme ingredient actif
UA28084C2 (uk)	2000-10-16	Протипухлинний засіб, виділений з слизової кишечника, спосіб його виділення
SE8006333L (sv)	1981-03-12	Polypeptid psp och salter derav
RU97114945A (ru)	1999-07-20	Белки против ожирения